Itraconazol 1 A Pharma (Itraconazole)

Itraconazole works by inhibiting the fungal enzyme lanosterol 14α‑demethylase, a cytochrome P450 isoform essential for converting lanosterol to ergosterol. Blocking this step disrupts the synthesis of ergosterol, a critical component of the fungal cell membrane, leading to increased membrane permeability and inhibition of fungal growth.

The dosage of Itraconazol 1 A Pharma is determined by the prescribing clinician based on the specific infection, severity, patient weight, renal and hepatic function, and other individual factors. Healthcare professionals select the appropriate strength, frequency and duration in accordance with current clinical guidelines and product labeling.

Safety data for itraconazole in pregnancy and lactation are limited, and the drug is classified as having an unknown pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the desired quantity of Itraconazol 1 A Pharma. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Itraconazole has a broader spectrum than fluoro‑azole agents, covering many molds such as Aspergillus and dimorphic fungi, whereas fluconazole is primarily active against Candida species. Itraconazole also has higher lipophilicity, leading to better tissue penetration, but it is more prone to drug‑drug interactions due to strong CYP3A4 inhibition. Choice of therapy depends on the pathogen, infection site and patient factors.

Itraconazol 1 A Pharma should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, humidity and direct sunlight, and ensure the container is tightly closed when not in use. Do not freeze or expose the medication to extreme temperatures.

The medication is taken orally, usually as tablets or capsules, and should be swallowed whole with a full glass of water. To improve absorption, it is recommended to take the dose with food, preferably a high‑fat meal. Patients should follow the prescribing clinician’s instructions regarding timing, duration and any required dose adjustments.

The most serious adverse events include hepatotoxicity, which can manifest as severe liver injury or failure; exacerbation of congestive heart failure due to fluid retention; and life‑threatening skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Prompt recognition of these signs and immediate discontinuation of therapy, followed by appropriate medical management, are essential.

Itraconazol 1 A Pharma is contraindicated in patients with known hypersensitivity to itraconazole or any azole antifungal, in individuals with a history of severe heart failure, and in those taking strong CYP3A4 inducers that would render the drug ineffective. Caution is also advised for patients with pre‑existing liver disease, uncontrolled arrhythmias, or those who are pregnant without a clear therapeutic justification.